You have 9 free searches left this month | for more free features.

AMD3100

Showing 1 - 25 of 81

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Relapsed Adult ALL, Relapsed Adult AML Trial in Changchun (Plerixafor)

Active, not recruiting
  • Relapsed Adult ALL
  • Relapsed Adult AML
  • Changchun, Jilin, China
    First Hospital of Jilin University
Nov 19, 2023

Healthy Trial run by the NHLBI (AMD 3100 (Mozobil plerixafor), Granulocyte colony-stimulating factor (G-CSF))

Completed
  • Healthy
  • AMD 3100 (Mozobil plerixafor)
  • Granulocyte colony-stimulating factor (G-CSF)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 21, 2021

Multiple Myeloma Trial in Stanford (MGTA-145, Plerixafor)

Completed
  • Multiple Myeloma
  • Stanford, California
    Stanford University
Aug 17, 2022

Autologous Haematopoietic Stem Cell Transplant Trial in China (plerixafor + G-CSF)

Recruiting
  • Autologous Haematopoietic Stem Cell Transplant
  • plerixafor + G-CSF
  • China, China
    Investigational Sites
May 4, 2022

Infertility of Uterine Origin Trial in San Francisco, Basking Ridge, Philadelphia (AMD3100, Normal saline, dilation and

Terminated
  • Infertility of Uterine Origin
  • AMD3100
  • +2 more
  • San Francisco, California
  • +2 more
May 18, 2021

Healthy Volunteers Trial run by the NHLBI (AMD3100)

Completed
  • Healthy Volunteers
  • AMD3100
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 5, 2020

Fanconi Anemia Trial in Cincinnati (AMD3100, AmCell CliniMACs)

Completed
  • Fanconi Anemia
  • AMD3100
  • AmCell CliniMACs
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Oct 28, 2020

Head Neck Cancer Trial in Boston (AMD3100, Pembrolizumab)

Withdrawn
  • Head and Neck Cancer
  • Boston, Massachusetts
  • +1 more
Sep 3, 2020

Allogeneic Hematopoietic Cell Transplantation (HCT), Advanced Hematologic Malignancies, Acute Leukemia Trial in Stanford

Recruiting
  • Allogeneic Hematopoietic Cell Transplantation (HCT)
  • +5 more
  • Purified regulatory T-cells (Treg) plus CD34+ HSPC
  • +7 more
  • Stanford, California
    Stanford University
Oct 28, 2021

Glioblastoma, Gliosarcoma Trial in Seattle (radiation, procedure, drug, biological, other)

Completed
  • Glioblastoma
  • Gliosarcoma
  • 3-Dimensional Conformal Radiation Therapy
  • +10 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Mar 4, 2022

Multiple Myeloma Trial in United States (Plerixafor, bortezomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • Boston, Massachusetts
  • +4 more
May 19, 2020

Stem Cell Transplantation, Leukemia Trial in Houston (Plerixafor, Filgrastim, Fludarabine)

Completed
  • Stem Cell Transplantation
  • Leukemia
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 22, 2020

Prostate Adenocarcinoma Trial in Washington (Entinostat, Enzalutamide)

Terminated
  • Prostate Adenocarcinoma
  • Washington, District of Columbia
    George Washington University - Medical Faculty Associates
Jul 26, 2021

Fanconi Anemia Trial in Barcelona, Madrid (procedure, biological, other, drug)

Unknown status
  • Fanconi Anemia
  • IV administration of Genetically Engineered Hematopoietic Stem/Progenitors Cells (HSPCs)
  • +5 more
  • Barcelona, Spain
  • +1 more
Nov 23, 2020

HLA-A*0201 Positive Cells Present, NY-ESO-1 Positive Tumor Cells Present, Recurrent Plasma Cell Myeloma Trial in Los Angeles

Withdrawn
  • HLA-A*0201 Positive Cells Present
  • +3 more
  • 18F-FHBG
  • +10 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jul 22, 2020

EVIS - Ex-vivo Assessment of T-lymphocyte Homing in Primary

Completed
  • Pancreatic Cancer
  • Whipples Surgery
  • Cambridge, England, United Kingdom
    Addenbrooke's Hospital
Jul 15, 2019

Poor Mobilizer (PM) in Multiple Myeloma (MM) Patients

Active, not recruiting
  • Multiple Myeloma
  • Torino, Italy
    A.O.U. Città della Salute e della Scienza di Torino
Aug 17, 2021

Healthy Trial run by the NHLBI (AMD3100 (Mozobil plerixafor))

Completed
  • Healthy
  • AMD3100 (Mozobil plerixafor)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Feb 5, 2018

Adult Ependymoblastoma, Adult Giant Cell Glioblastoma, Adult Glioblastoma Trial in Stanford (radiation, drug, other)

Completed
  • Adult Ependymoblastoma
  • +8 more
  • radiation therapy
  • +4 more
  • Stanford, California
    Stanford University, School of Medicine
Sep 27, 2018

Melanoma Trial in United States (X4P-001, Pembrolizumab)

Completed
  • Melanoma
  • Atlanta, Georgia
  • +3 more
Jul 1, 2020

High Grade Glioma: Glioblastoma (GBM), High Grade Glioma: Gliosarcoma, Anaplastic Astrocytoma (AA) Trial in Boston (Plerixafor,

Terminated
  • High Grade Glioma: Glioblastoma (GBM)
  • +4 more
  • Boston, Massachusetts
  • +1 more
Nov 15, 2017

Relapsed/Refractory AML, Relapsed/Refractory ALL, Secondary AML/MDS Trial in Canada, United States (Plerixafor Dose Escalation)

Completed
  • Relapsed/Refractory AML
  • +5 more
  • Plerixafor Dose Escalation
  • Phoenix, Arizona
  • +8 more
Sep 5, 2018

Acute Myeloid Leukemia, Acute Lymphoid Leukemia Trial in Mexico City (Busulfan, Cyclophosphamide, CXCR4 Antagonist)

Unknown status
  • Acute Myeloid Leukemia
  • Acute Lymphoid Leukemia
  • Mexico City, Distrito Federal, Mexico
    Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubi
Jan 10, 2020

Malignant Lymphoma, Stem Cell Type Trial in Halifax (Plerixafor (Mozobil), Plerixafor + G-CSF)

Completed
  • Malignant Lymphoma, Stem Cell Type
  • Plerixafor (Mozobil)
  • Plerixafor + G-CSF
  • Halifax, Nova Scotia, Canada
    Capital Health District Authority
Jul 31, 2017

Hematologic Tumors Trial in St. Louis (AMD3100, Leukopheresis, Stem cell transplant)

Completed
  • Hematologic Neoplasms
  • AMD3100
  • +2 more
  • St. Louis, Missouri
    Washington University School of Medicine
Apr 6, 2017